Functional Reserve Estimation of Donor Kidney

NCT ID: NCT01689272

Last Updated: 2015-02-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-05-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study:

* To estimate the role of morphological, clinical, biochemical and imaging studies at stages of kidney transplantation (medical therapy, explantation, preservation, transplantation).
* To improve the ways of preserving optimal functional parameters of renal transplants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Terminal chronic renal failure (ESRD) as a result of almost any chronic kidney disease develops due to progressive loss of nephrons. This state is characterized by a gradual deterioration of the functional abilities of not only the kidneys, but also the whole body. Currently, ESRD is among the first ten causes of mortality .

Transplantation of donor organs is the only radical treatment for various diseases of the terminal, for patients with a fatal prognosis.

Kidney transplantation has allowed not only save lives, but also to return to normal life, tens of thousands of people. Survival of renal transplant recipients is growing.

Despite the progress made in many clinics worldwide in recent years in the field of transplantation, kidney transplantation, does not settle the problem of reperfusion injury and the associated post-transplant dysfunction with the absence of clear indicators of morphological, clinical, biochemical and instrumental methods to assess functional reserve of organs that remain relevant and meaningful.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End-stage Renal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kidney transplantation

Kidney transplantation from alive relative donor.

Group Type EXPERIMENTAL

Kidney Transplantation from alive relative donor

Intervention Type PROCEDURE

Donor kidney sampling, preservation, transport and transplantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kidney Transplantation from alive relative donor

Donor kidney sampling, preservation, transport and transplantation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* recipients-patients with end-stage renal disease;
* donor healthy people without absolute contraindications to the kidney transplantation;
* donor and recipients who are both in the genetic and non-genetic related to each other.
* obligatory immunological compatibility by HLA-phenotyping provided that the donor and recipient are not relatives with each other;
* negative result of cross-match between donors and recipients;
* presence of pre-existing lymphotoxic antibodies in a recipient less than 50%;
* absence of standard absolute contraindications in a donor and in a recipient for surgeric intervention.

Age is 18-60 years.

Exclusion Criteria

* patients with absolute contraindications to surgery: diseases of organs and systems having a threating risk to the life of donor and recipient during and after surgery;
* immunological incompatibility between donor and recipient;
* high level of pre-existing lymphotoxic antibodies in a recipient more than 50%, uncorrected by Therapy;
* donor age is under 18 and over 60 years;
* incapable persons;
* absence of a notarized consent form to kidney transplantation;
* presence of the active phase of viral infection with hepatitis B and C;
* positive results of blood tests for HIV/AIDS, syphilis;
* patients with severe concomitant pathology of kidneys, (or) heart and (or)liver.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nazarbayev University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gani M Kuttymuratov, Phd

Role: PRINCIPAL_INVESTIGATOR

Advisor to the Board Chairman

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Republican Scientific Center for Emergency Medicine

Astana, , Kazakhstan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Kazakhstan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0111RK00337

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MRI in Renal Transplantation
NCT03705091 UNKNOWN